Core Viewpoint - China Railway Signal and Communication Group Co., Ltd. (通号集团) plans to divest its entire stake in Kaifa Electric (凯发电气), amounting to 36.6869 million shares, which represents 11.63% of the total share capital after excluding shares in the company's repurchase account [1] Group 1: Shareholding Changes - The divestment will result in 通号集团 no longer holding any shares in Kaifa Electric, where it was the second-largest shareholder as of September 30 [1] - 通号集团 initially acquired shares in Kaifa Electric on December 26, 2018, through a share transfer agreement, purchasing 14.2263 million shares at a price of 6.45 yuan per share, totaling approximately 91.76 million yuan [2] - After subsequent investments in convertible bonds, 通号集团's total equity stake in Kaifa Electric was calculated to be 11.18% if all bonds were converted at the initial conversion price of 8.15 yuan per share [2] Group 2: Company Development Plans - Kaifa Electric recently announced a plan to raise 300 million yuan through a private placement to fund technology upgrades and the development of a power supply automation product platform [3] - The company is transitioning from traditional power supply automation systems to higher-value products, including intelligent power supply dispatch and smart monitoring systems, necessitating advanced technology [3] - The funds raised will support the establishment of an integrated production line for power supply automation products, enhancing product quality and reducing costs while aligning with national strategic goals for self-controlled technology [3]

分组1 - Weili Medical plans to distribute a cash dividend of 2 yuan per 10 shares to all shareholders, based on an undistributed profit of 704 million yuan as of September 30, 2025 [1] - Tongding Interconnect's shareholder plans to reduce their stake by up to 0.49%, equating to a maximum of 605,800 shares [1] - Caitong Securities has received approval from the China Securities Regulatory Commission to issue short-term corporate bonds with a total face value of up to 5 billion yuan [1] 分组2 - Youfu Food intends to use 70 million yuan of its own funds to invest in wealth management products with expected annual returns of up to 4.2% [3] - Keres received an administrative regulatory decision from the Guangdong Securities Regulatory Bureau for violations related to accounts receivable aging calculations and related party transactions [5] - Ouma Software's controlling shareholder has completed the transfer of state-owned equity, changing the controlling shareholder to Shandong Guotou [7] 分组3 - ST Huapeng's wholly-owned subsidiary has completed a major overhaul project and is now in production [8] - Beiqi Blue Valley has received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [8] - Weijie Chuangxin received a government subsidy of 5 million yuan, accounting for 21.07% of its projected net profit for 2024 [9] 分组4 - China Resources Double Crane's subsidiary has received a drug registration certificate for a hypertension treatment drug [11] - Huafeng shares are continuing to suspend trading due to a planned change in control [13] - Kaifa Electric's shareholder plans to transfer 36.6869 million shares, representing 11.63% of the total share capital [14] 分组5 - Heng Rui Medicine has received approval for two clinical trials for innovative anti-tumor drugs [15] - Kosen Technology plans to invest 30 million USD to establish a new production base in Malaysia [17] - Sanxing Medical's subsidiary is expected to win a procurement project from the State Grid worth approximately 107 million yuan [18] 分组6 - Sitai Li's subsidiary has received a drug registration certificate for a contrast agent used in MRI [21] - Daren Tang's subsidiary has received a drug registration certificate for a pain relief gel [22] - Saike Xide has received approval for three medical device products, expanding its product range in the in vitro diagnostic field [23] 分组7 - Hasa Lian has elected a new chairman and vice chairman for its board of directors [24] - Two-sided Needle's subsidiary plans to invest 68.8522 million yuan in a production base expansion project [25] - Sunshine Nuohe plans to transfer 70% of its controlling subsidiary's equity for 2 million yuan [26] 分组8 - Hengbang shares received an administrative regulatory decision from the Shandong Securities Regulatory Bureau for failing to complete the election of independent directors [27] - Huali shares plan to sign a related transaction contract worth approximately 59.2847 million yuan [28] - Shangwei shares plan to invest 520.4 million yuan to gain a controlling stake in Sichuan Zhongfu Taihua [30] 分组9 - Zejing Pharmaceutical's ZG006 has been included in the list of breakthrough therapeutic varieties for treating advanced neuroendocrine cancer [32] - Yaopi Glass's shareholder plans to reduce their stake by up to 2.26%, equating to a maximum of 21.1469 million shares [34] - Huate Gas has initiated a major lawsuit involving a claim of 180 million yuan [36] 分组10 - Zhongchumei's controlling shareholder plans to increase their stake by between 42 million and 80 million yuan [37] - Huitong shares' shareholder plans to reduce their stake by up to 1% [38] - Miaowei Exhibition plans to apply for an initial public offering of H shares on the Hong Kong Stock Exchange [40] 分组11 - Tianqi Lithium's subsidiary has appealed to the Chilean Supreme Court regarding a partnership agreement with SQM and Codelco [42] - Naxin Micro plans to repurchase shares worth between 200 million and 400 million yuan [44] - Pingao shares have reported significant uncertainty regarding future business development and profitability [46] 分组12 - Shunyu shares have been pre-selected for a project worth 1.023 billion yuan [48] - Zhongyuan Neipei plans to acquire a 2.5% share in an aerospace industry fund for 50 million yuan [50] - Huifa Food's shareholder plans to reduce their stake by up to 3%, equating to a maximum of 727.14 million shares [53] 分组13 - Junshi Biosciences' subcutaneous PD-1 new formulation has reached its primary endpoint in a Phase III clinical trial [54] - Industrial Fulian clarified that it has not lowered its fourth-quarter profit target amid market rumors [55] - Longpan Technology's subsidiary has signed a major supply agreement for lithium iron phosphate materials, significantly increasing the supply volume [56]

Core Viewpoint - The major shareholder, Tonghao Group, plans to publicly solicit the transfer of 36,686,852 shares of Kaifa Electric, representing 11.63% of the total share capital after excluding repurchased shares, and will no longer hold shares after the transfer [1] Group 1 - The transfer has been approved by the board of Tonghao Group but is subject to approval from state-owned asset management departments, making the entry into the solicitation process and the identity of the transferee uncertain [1] - The transfer price will not be lower than the higher of the arithmetic average of the weighted average price over the last 30 trading days prior to the announcement and the audited net asset value per share for the last year, with adjustments for any ex-rights or ex-dividend events [1]

根据《上市公司国有股权监督管理办法》，本次公开征集转让的价格不低于提示性公告日（2025年11月 26日）前30个交易日的每日加权平均价格的算术平均值及最近一个会计年度公司经审计每股净资产值两 者之中的较高者。本次公开征集转让完成前，如果公司发生派息、送股、资本公积金转增股本、配股等 除权、除息事项，则转让价格相应调整。本次拟转让股份的最终转让价格将依据相关法规，以公开征集 并经通号集团批复的结果确定。 格隆汇11月25日丨凯发电气(300407.SZ)公布，公司持股5%以上股东中国铁路通信信号集团有限公司 （简称"通号集团"）拟通过公开征集转让的方式协议转让其持有的公司36,686,852股股份，占剔除公司 回购专用账户中的股份数量后总股本的11.63%。本次股份转让完成后，通号集团将不再持有公司股 份。 ...

证券代码：300407 证券简称：凯发电气 公告编号：2025-062 天津凯发电气股份有限公司 关于持股 5%以上股东拟通过公开征集转让 方式转让公司股份的提示性公告 通号集团目前直接持有公司 36,686,852 股股份，占剔除公司回购专用账户中 股份数量（2,851,349 股）后总股本 315,349,144 股的 11.63%，该部分股票均为无 限售条件股。通号集团拟通过公开征集转让的方式协议转让其持有的公司 36,686,852 股股份，占剔除公司回购专用账户中的股份数量后总股本的 11.63% （以下简称"本次公开征集转让"）。在此期间，公司如有送股、资本公积转增股 本等股本变动事项，公开征集转让股份数量进行相应调整。 根据《上市公司国有股权监督管理办法》，本次公开征集转让的价格不低于 提示性公告日（2025 年 11 月 26 日）前 30 个交易日的每日加权平均价格的算术 平均值及最近一个会计年度公司经审计每股净资产值两者之中的较高者。本次公 开征集转让完成前，如果公司发生派息、送股、资本公积金转增股本、配股等除 权、除息事项，则转让价格相应调整。本次拟转让股份的最终转让价格将依据相 关法规 ...

（文章来源：证券日报） 证券日报网讯凯发电气11月24日在互动平台回答投资者提问时表示，截至2025年11月20日公司股东户数 为17829户。 ...

截至发稿，杨梦累计任职时间7年106天，现任基金资产总规模188.56亿元，任职期间最佳基金回报 170.55%， 任职期间最差基金回报-27.34%。 数据显示，博道基金旗下1只基金位居凯发电气十大流通股东。博道成长智航股票A（013641）三季度 新进十大流通股东，持有股数310.68万股，占流通股的比例为1.29%。根据测算，今日浮亏损失约 192.62万元。连续6天下跌期间浮亏损失574.75万元。 博道成长智航股票A（013641）成立日期2021年10月26日，最新规模22.45亿。今年以来收益40.87%， 同类排名756/4208；近一年收益43.03%，同类排名445/3972；成立以来收益39.88%。 博道成长智航股票A（013641）基金经理为杨梦。 11月21日，凯发电气跌5.07%，截至发稿，报11.62元/股，成交7231.26万元，换手率2.53%，总市值 36.97亿元。凯发电气股价已经连续6天下跌，区间累计跌幅13.13%。 资料显示，天津凯发电气股份有限公司位于天津滨海高新技术产业开发区华苑产业区(环外)海泰发展二 路15号，成立日期2000年1月25日，上市日期2014 ...

（文章来源：证券日报） 证券日报网讯 11月20日晚间，凯发电气发布公告称，公司于2025年11月20日召开第六届董事会第十七 次会议，审议通过了《关于第二期限制性股票激励计划第一个归属期归属条件成就的议案》。 ...

（文章来源：证券日报） 证券日报网讯 11月20日晚间，凯发电气发布公告称，公司于2025年11月20日召开了第六届董事会第十 七次会议，审议通过了《关于第二期限制性股票激励计划作废部分已授予尚未归属的第二类限制性股票 的议案》。 ...

（文章来源：证券日报） 证券日报网讯 11月20日晚间，凯发电气发布公告称，根据天津凯发电气股份有限公司（以下简称"公 司"）2024年第一次临时股东大会的授权，公司于2025年11月20日召开了第六届董事会第十七次会议， 审议通过了《关于调整第二期限制性股票激励计划第二类限制性股票授予价格的议案》，同意根据《天 津凯发电气股份有限公司第二期限制性股票激励计划》（以下简称"激励计划"）的相关规定，对公司第 二期限制性股票激励计划第二类限制性股票授予价格进行调整。 ...